Cargando…

Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy

A growing line of evidence indicates a dysfunctional ubiquitin-proteasome system (UPS) in cardiac diseases. Anti-hypertrophic effects and improved cardiac function have been reported after treatment with proteasome inhibitors in experimental models of cardiac hypertrophy. Here we tested whether prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlossarek, Saskia, Singh, Sonia R., Geertz, Birgit, Schulz, Herbert, Reischmann, Silke, Hübner, Norbert, Carrier, Lucie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267180/ https://www.ncbi.nlm.nih.gov/pubmed/25566086 http://dx.doi.org/10.3389/fphys.2014.00484

Ejemplares similares

A Transgenic Mouse Model of Eccentric Left Ventricular Hypertrophy With Preserved Ejection Fraction Exhibits Alterations in the Autophagy-Lysosomal Pathway
por: Wenzel, Kristin, et al.
Publicado: (2021)

Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model
por: Stücker, Sabrina, et al.
Publicado: (2017)

Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice
por: Gedicke-Hornung, Christina, et al.
Publicado: (2013)

I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model
por: Friedrich, Felix W., et al.
Publicado: (2015)

Myoarchitectural disarray of hypertrophic cardiomyopathy begins pre‐birth
por: Garcia‐Canadilla, Patricia, et al.
Publicado: (2019)

A high-throughput screening identifies ZNF418 as a novel regulator of the ubiquitin-proteasome system and autophagy-lysosomal pathway
por: Singh, Sonia R, et al.
Publicado: (2020)

Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
por: Kresin, Nico, et al.
Publicado: (2019)

Classifying Cardiac Actin Mutations Associated With Hypertrophic Cardiomyopathy
por: Despond, Evan A., et al.
Publicado: (2018)

The embryological basis of subclinical hypertrophic cardiomyopathy
por: Captur, Gabriella, et al.
Publicado: (2016)

FHL2 expression and variants in hypertrophic cardiomyopathy
por: Friedrich, Felix W., et al.
Publicado: (2014)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Kawana, Masataka, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation
por: Veltri, Tiago, et al.
Publicado: (2017)

Increased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy
por: Farrell, Emily T., et al.
Publicado: (2017)

S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue
por: Braumann, Simon, et al.
Publicado: (2018)

Image-Based Computational Hemodynamics Analysis of Systolic Obstruction in Hypertrophic Cardiomyopathy
por: Fumagalli, Ivan, et al.
Publicado: (2022)

Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Frontiers Production Office,
Publicado: (2022)

Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy
por: Mearini, Giulia, et al.
Publicado: (2013)

Hypertrophic cardiomyopathy: a heart in need of an energy bar?
por: Vakrou, Styliani, et al.
Publicado: (2014)

Diabetes outcomes in heart failure patients with hypertrophic cardiomyopathy
por: Mekhaimar, Menatalla, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation
por: Chalovich, J. M., et al.
Publicado: (2022)

Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants
por: Kraker, Jessica, et al.
Publicado: (2016)

Altered Ca(2+) and Na(+) Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis
por: Coppini, Raffaele, et al.
Publicado: (2018)

Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D
por: Herwig, Melissa, et al.
Publicado: (2020)

Mechanisms of Arrhythmogenicity in Hypertrophic Cardiomyopathy: Insight From Non-invasive Electrocardiographic Imaging
por: Perez-Alday, Erick A., et al.
Publicado: (2020)

Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction
por: Zhao, Xiaodan, et al.
Publicado: (2018)

Numerical Simulation Study on the Mechanism of Formation of Apical Aneurysm in Hypertrophic Cardiomyopathy With Midventricular Obstruction
por: Deng, Long, et al.
Publicado: (2021)

Altered coronary artery function, arteriogenesis and endothelial YAP signaling in postnatal hypertrophic cardiomyopathy
por: Langa, Paulina, et al.
Publicado: (2023)

Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy
por: Prondzynski, Maksymilian, et al.
Publicado: (2019)

Proteomic Analysis of Myocardia Containing the Obscurin R4344Q Mutation Linked to Hypertrophic Cardiomyopathy
por: Hu, Li-Yen R., et al.
Publicado: (2020)

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
por: Pioner, Josè Manuel, et al.
Publicado: (2022)

Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling
por: Farrell, Emily, et al.
Publicado: (2018)

Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue
por: Dutsch, Alexander, et al.
Publicado: (2019)

Effects of Hypertrophic and Dilated Cardiac Geometric Remodeling on Ejection Fraction
por: Zheng, Yu, et al.
Publicado: (2022)

Familial hypertrophic cardiomyopathy: functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development
por: Brenner, Bernhard, et al.
Publicado: (2014)

Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers
por: Lyon, Aurore, et al.
Publicado: (2018)

Investigations into the Sarcomeric Protein and Ca(2+)-Regulation Abnormalities Underlying Hypertrophic Cardiomyopathy in Cats (Felix catus)
por: Messer, Andrew E., et al.
Publicado: (2017)

Altered contractility in mutation-specific hypertrophic cardiomyopathy: A mechano-energetic in silico study with pharmacological insights
por: Forouzandehmehr, Mohamadamin, et al.
Publicado: (2022)

Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
por: Cordts, Kathrin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8lg7e1a51reo46lla9kd0qj3hv